# Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies

> **NCT02306837** · PHASE2 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 40 (estimated)

## Conditions studied

- Effects of Chemotherapy

## Interventions

- **DRUG:** Bu-CY-E

## Key facts

- **NCT ID:** NCT02306837
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2018-09
- **Final completion:** 2019-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306837, "Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02306837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*